<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03511677</url>
  </required_header>
  <id_info>
    <org_study_id>20634013.9.0000.5505.</org_study_id>
    <nct_id>NCT03511677</nct_id>
  </id_info>
  <brief_title>Insole on Morton's Neuroma</brief_title>
  <official_title>Effectiveness of Insole on Morton's Neuroma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: The aim of the present study was to assess the effectiveness of insole with
      metatarsal support on pain in patients with Morton`s neuroma and the impact of this insole on
      function, load distribution in the plantar region, gait variables, quality of life and
      satisfaction with insole use.

      Methods: A randomized, controlled, double-blind, clinical trial with intent-to-treat
      analysis. Seventy-two patients with Morton`s neuroma were randomly allocated into a study
      group and control group. One week following the baseline evaluation, the study group received
      insole with metatarsal support made of ethyl vinyl acetate and the control group received a
      flat insole of the same material, color and density. The groups were evaluated after 6, 12
      and 24 weeks of insole use. The following assessment parameters employed: pain when walking
      and at rest (END); quality of life (SF-36); foot function (FFI and FHSQ); six-minute walk
      test (6MWT) and foot pressure analysis using the AM Cube FootWalk Pro program.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2015</start_date>
  <completion_date type="Actual">March 31, 2018</completion_date>
  <primary_completion_date type="Actual">March 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Placebo insole</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in pain</measure>
    <time_frame>Baseline, after 6, 12 and 24 weeks</time_frame>
    <description>Measured by visual analogue scale from 0 cm to 10 cm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in function and foot health</measure>
    <time_frame>Baseline, after 6, 12 and 24 weeks</time_frame>
    <description>Measured by Foot function index questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in function, foot healt and quality of life</measure>
    <time_frame>Baseline, after 6, 12 and 24 weeks</time_frame>
    <description>Measured by Foot Health Status questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in function</measure>
    <time_frame>Baseline, after 6, 12 and 24 weeks</time_frame>
    <description>Measured by the distance in the six minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline, after 6, 12 and 24 weeks</time_frame>
    <description>Measured by the Short Form -36 questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Morton Neuroma</condition>
  <arm_group>
    <arm_group_label>Intervention Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Customized insole with metatarsal support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo flat insole</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Insole</intervention_name>
    <description>Customized insole</description>
    <arm_group_label>Intervention Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo Insole</intervention_name>
    <description>Placebo flat insole</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with clinical and radiological diagnosis (magnetic resonance or ultrasound) of
             Morton's neuroma.

          -  Pain in the foot with VAS between 3-8 cm to walk.

          -  Over 18 years.

          -  No distinction of sex

          -  Agree to participate of the study and sign the informed consent form.

        Exclusion Criteria:

          -  Other symptomatic musculoskeletal diseases in MMII.

          -  Symptomatic diseases of the central and peripheral nervous system.

          -  Diabetes Mellitus.

          -  Rigid deformities on foot.

          -  Use of insoles in the last three months.

          -  Physiotherapy in the last three months.

          -  Infiltrations on foot and ankles in the last three months.

          -  Previous or expected surgery in the next twelve months.

          -  Allergy to the material of the insole.

          -  Mental deficiency.

          -  Geographic inaccessibility .- Use of corticosteroids or NSAIDs in the last month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>April 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2018</study_first_posted>
  <last_update_submitted>April 26, 2018</last_update_submitted>
  <last_update_submitted_qc>April 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of São Paulo</investigator_affiliation>
    <investigator_full_name>Hilda Alcantara Veiga de Oliveira</investigator_full_name>
    <investigator_title>PT, MsC</investigator_title>
  </responsible_party>
  <keyword>Insole</keyword>
  <keyword>Morton Neuroma</keyword>
  <keyword>Pain</keyword>
  <keyword>Function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuroma</mesh_term>
    <mesh_term>Morton Neuroma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

